Illegal ayurvedic medicine factory busted in Valsad, raw materials, machinery seized

Valsad:  A factory manufacturing Ayurvedic medicines illegally has been busted behind the Vishwambhari temple in Rabda, Valsad district of Gujarat. Food and Drug Administration (FDA) officials have raided the factory and taken massive action.

During the raid, the FDA has found a large quantity of various types of Ayurvedic medicines, such as powder, pills, tablets, extracts, soaps and oils. In addition, raw materials and machinery used to make the medicine have also been seized.
Preliminary investigation has revealed that this factory was running without any proper permission. This factory was manufacturing medicines illegally in violation of the guidelines of the Food and Drug Department.

Samples of the seized medicines have been sent to the laboratory so that their quality and safety can be assessed. Further legal action will be taken after receiving the laboratory report.

This incident has raised concerns about illegal Ayurvedic medicine manufacturing in Gujarat. FDA is continuously monitoring such illegal activities and strict action will be taken.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre